
EORTC GUCG YI
@eortc_gucg_yeci
Young & Early Carreer Investigators @EORTC GU cancer group
ID: 1648996144368820224
20-04-2023 10:25:03
61 Tweet
34 Followers
70 Following



Congrats to Tom Powles !


🩺 On European Urology - Oligometastatic Bladder Cancer: Defining a Novel Entity #BladderCancer Chris Labaki Toni Choueiri, MD Eddy Saad joaquim bellmunt europeanurology.com/article/S0302-…




At what PSA level do experts recommend imaging for high-risk prostate cancer patients after radical RT and systemic therapy? The opinions are split! #Apccc24 Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin OncoAlert Thomas Zilli Daniel Castellano Piet Ost Emre Yekedüz Dra. María Natalia Gandur Quiroga


Now more than ever, it is important to propose de-escalation strategies. EORTC 2238 "De-Escalate" will address the specific question of intermittent therapy in these mHSPC patients ! tombal silke gillessen Fabio Turco Advanced Prostate Cancer Consensus Conference EORTC OncoAlert


There is more than PET-PSMA to monitor tumor response in advance PCa. Julien Van Damme Vassiliki Pasoglou fred lecouvet Anwar Padhani sciencedirect.com/science/articl…


Nice talk by Valeria Panebianco about NacVI-RADS and how to reassess neoadjuvant treatment in MIBC !


Nice talk by Dr Masson-Lecomte on the importance of defining the response to NAT, as well as the importance of multimodal assessment. Question will be answered by the EORTC2418 - ‘STARBURST’ study !#EORTC #EMUC24 Yohann Loriot Vérane Achard Julien Van Damme Guillaume Grs tombal


EMUC 24 The discussion is focused on MRI as a tool for response to therapy assessment selecting pts for bladder preservation Laura S. Mertens Paolo Gontero Alex-lecomte ToinevanderHeijden


Fabio Turco presenting PEACE3 at EMUC, great efficacy and low toxicity of Radium in early mCRPC. The ideal therapy to layer on ARPI? Probably. EORTC silke gillessen EORTC GUCG YI





Guillaume Grs silke gillessen Fabio Turco I understand the enthusiasm but there is no data confirming OS gain is maintainned frontiersin.org/journals/oncol…
